Literature DB >> 32319323

Irisin ameliorates bone loss in ovariectomized mice.

Y Luo1,2,3,4, Y Ma1,2,3,4, X Qiao1,2,3,4, R Zeng1,2,3,4, R Cheng1,2,3,4, Y Nie1,2,3,4, S Li1,2,3,4, R A1,2,3,4, X Shen1,2,3,4, M Yang1,2,3,4, C C Xu5, L Xu1,2,3,4.   

Abstract

Purpose: This study aimed to evaluate the effects of irisin on bones of ovariectomized (OVX) mice, to explore a possible treatment for postmenopausal osteoporosis.
Methods: The OVX mice were treated with intraperitoneal injections of recombinant irisin (r-irisin) or saline twice a week for 5 weeks. The trabecular bone structure of the femur, the bone strength of the tibia, and serum parameters were assessed.
Results: Treatment with r-irisin prevented the trabecular bone loss of the OVX mice. The r-irisin-treated OVX mice exhibited a greater bone microarchitecture, with significantly increased bone mineral density, bone volume to tissue volume ratio, connection density, and trabecular number parameters compared to those of the saline-treated OVX mice. The improved bone microarchitecture induced an increased bone stiffness in r-irisin-treated OVX mice. Consistently, the OVX mice treated with r-irisin showed a significantly increased number of osteoblasts on the trabecular surface and a significantly decreased number of osteoclasts. The r-irisin-treated OVX mice also had a higher osteocalcin level and a lower tartrate-resistant acid phosphatase concentration in serum.
Conclusion: Irisin increases osteoblasts and decreases the number of osteoclasts, which leads to the maintenance of bone mass and quality in OVX mice. Irisin likely preserves the bone microarchitecture via building a 'new balance'. Therefore, our study extended the understanding of the role of irisin in bone metabolism and revealed the possibility of therapeutic application of irisin for postmenopausal osteoporosis.

Entities:  

Keywords:  Postmenopausal osteoporosis; bone parameters; exercise-induced irisin; ovariectomized

Mesh:

Substances:

Year:  2020        PMID: 32319323     DOI: 10.1080/13697137.2020.1745768

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  14 in total

Review 1.  Physical Activity and Post-Transcriptional Regulation of Aging Decay: Modulation of Pathways in Postmenopausal Osteoporosis.

Authors:  Federica Vita; Sebastiano Gangemi; Giovanni Pioggia; Fabio Trimarchi; Debora Di Mauro
Journal:  Medicina (Kaunas)       Date:  2022-06-06       Impact factor: 2.948

Review 2.  Role of the Myokine Irisin on Bone Homeostasis: Review of the Current Evidence.

Authors:  Amanda Kornel; Danja J Den Hartogh; Panagiota Klentrou; Evangelia Tsiani
Journal:  Int J Mol Sci       Date:  2021-08-24       Impact factor: 6.208

Review 3.  A Bibliometric Analysis of the Literature on Irisin from 2012-2021.

Authors:  Jiangshan Liu; Bote Qi; Lin Gan; Yanli Shen; Yu Zou
Journal:  Int J Environ Res Public Health       Date:  2022-05-18       Impact factor: 4.614

Review 4.  [Research progress on mechanism of myokines regulating bone tissue cells].

Authors:  Hongcheng Peng; Zhen Hua; Huilin Yang; Jianwei Wang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-07-15

5.  Disordered metabolism in mice lacking irisin.

Authors:  Yunyao Luo; Xiaoyong Qiao; Yaxian Ma; Hongxia Deng; Charles C Xu; Liangzhi Xu
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

6.  Irisin Regulating Skeletal Response to Endurance Exercise in Ovariectomized Mice by Promoting Akt/β-Catenin Pathway.

Authors:  Renqing Zhao; Yalan Zhou; Jinqiao Li; Junjie Lin; Wei Cui; Yan Peng; Wenqian Bu
Journal:  Front Physiol       Date:  2021-03-25       Impact factor: 4.566

7.  The Association of Serum Irisin with Bone Mineral Density and Turnover Markers in New-Onset Type 2 Diabetic Patients.

Authors:  Xiujing Wang; Tianxiao Hu; Yun Ruan; Jiaqi Yao; Huiling Shen; Yao Xu; Bojing Zheng; Zhengying Zhang; Jing Wang; Qingying Tan
Journal:  Int J Endocrinol       Date:  2022-02-28       Impact factor: 2.803

8.  Lower Serum Irisin Levels Are Associated with Increased Osteoporosis and Oxidative Stress in Postmenopausal.

Authors:  Ali Badr Roomi; Wassan Nori; Roaa Mokram Hamed
Journal:  Rep Biochem Mol Biol       Date:  2021-04

Review 9.  Progress and Challenges in the Biology of FNDC5 and Irisin.

Authors:  Steffen Maak; Frode Norheim; Christian A Drevon; Harold P Erickson
Journal:  Endocr Rev       Date:  2021-07-16       Impact factor: 19.871

Review 10.  Irisin: circulating levels in serum and its relation to gonadal axis.

Authors:  Yunyao Luo; Xiaoyong Qiao; Liangzhi Xu; Guoning Huang
Journal:  Endocrine       Date:  2022-01-17       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.